A high-throughput drug screen reveals means to differentiate triple-negative breast cancer
Milica Vulin(University of Basel), Mohamed Bentires‐Alj(University of Basel)
Cited by 13
Related Papers
Activating Mutations of the Noonan Syndrome-Associated <b> <i>SHP2/PTPN11</i> </b> Gene in Human Solid Tumors and Adult Acute Myelogenous Leukemia
|Cancer Research|2004|512
Calcium-activated chloride channel ANO1 promotes breast cancer progression by activating EGFR and CAMK signaling
|Proceedings of the National Academy of Sciences|2013|321
Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase
|Cell|2011|276
Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition
|Breast Cancer Research|2016|125